文献速递传染病防控与疫情报告免疫规划

猪源细胞培养灭活塞内卡谷病毒疫苗的免疫原性与保护效力

Immunogenicity and protective efficacy of an inactivated cell culture-derived Seneca Valley virus vaccine in pigs.
PubMed 文献 · Vaccine · 2018-01-05

研究以BHK-21细胞培养、二元乙撑亚胺灭活并混合油佐剂(Montanide ISA)制备SVV CH-FJ-2017灭活疫苗,猪只接种一剂(2 μg/剂)后经中和试验评估免疫原性并以同株病毒攻击。免疫猪产生高中和抗体滴度,攻毒后无临床症状,未免疫猪则出现临床症状,显示良好保护效力。

要点

  • SVV CH-FJ-2017灭活疫苗经BHK-21细胞培养、二元乙撑亚胺灭活并混合油佐剂制成。
  • 猪只接种一剂2 μg/剂疫苗后产生高中和抗体滴度。
  • 免疫猪攻毒后无临床症状,未免疫猪出现临床症状,显示良好保护效力。

核心结论

  • 接种一剂含油佐剂的SVV CH-FJ-2017灭活疫苗(2 μg/剂)的猪只产生高中和抗体滴度,攻毒后无临床症状,显示良好保护效力。
  • 这是首次报道可用于控制猪SVV感染的疫苗。

研究设计与样本

  • 研究以BHK-21细胞在滚瓶中培养SVV CH-FJ-2017,经二元乙撑亚胺灭活后与油佐剂(Montanide ISA)混合制备灭活疫苗。
  • 猪只接种一剂疫苗(2 μg/剂)后通过中和试验评估免疫原性,并以SVV CH-FJ-2017攻毒。

主要发现

  • 接种一剂2 μg/剂含油佐剂灭活疫苗的猪只产生高中和抗体滴度。
  • 免疫猪攻毒后无临床症状,未免疫猪出现临床症状。
  • SVV CH-FJ-2017与近期SVV毒株的衣壳蛋白氨基酸一致性为98.5-99.9%。

关键数值与推荐

  • 疫苗剂量为2 μg/剂,接种一剂,含油佐剂(Montanide ISA)。
  • 免疫原性通过中和试验评估,攻毒用SVV CH-FJ-2017株。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Seneca Valley virus (SVV) infection in pigs is associated with porcine idiopathic vesicular disease (PIVD). Outbreaks of SVV infection in pig herds have been reported in several Asia and Americas countries. Recently, a series of outbreaks of SVV infection occurred in China, Canada, Thailand and the United States. However, no available vaccines have been developed to limit the transmission of SVV. The SVV CH-FJ-2017 from Fujian province in China is a representative of the epidemic strains, and shows 98.5-99.9% capsid protein amino acid identity with the recent SVV strains. In the present study, we developed a SVV CH-FJ-2017 inactivated vaccine. The SVV was produced by cultivation of BHK-21 cells in roller bottles, inactivated with binary ethylenimine, and mixed with oil adjuvant (Montanide ISA). The immunogenicity of the inactivated vaccine in pigs was evaluated by neutralizing test, and the immunized pigs were challenged with SVV CH-FJ-2017. The results showed that animals receiving one dose of the inactivated vaccine (2 μg/dose) with oil adjuvant developed high neutralizing antibody titers and showed no clinical signs after virus challenge comparing with the non-vaccinated animals, indicating a good protective efficacy of the produced vaccine against SVV infection. This is the first reported SVV vaccine that can be used for control of SVV infection in pigs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yang F, Zhu Z, Cao W, et al. Immunogenicity and protective efficacy of an inactivated cell culture-derived Seneca Valley virus vaccine in pigs. Vaccine. 2018. PMID: 29310900. doi:10.1016/j.vaccine.2017.12.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。